← Eichor
Study identifier: NCT06383143 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Promoting Diagnosis and Management of AL in Italy (ProDigALIty)

Condition: AL Amyloidosis · Smoldering Multiple Myeloma · Monoclonal Gammopathy of Undetermined Significance  ·  Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia

PhaseN/A
Planned participants760
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

The investigators plan to establish a dedicated network of Italian Hematologic Departments interconnected with the Amyloidosis Research and Treatment Center in Pavia to: 1. Implement a biomarker-based screening strategy to promote early diagnosis of AL amyloidosis among at-risk patients, including patients with monoclonal gammopathy of undetermined significance, MGUS, and altered free light chain ratio (aFLCR), and patients with smoldering multiple myeloma (SMM) 2. Expedite and facilitate patients' referral and their enrollment in ongoing pre-clinical/clinical studies, also to reflect a broader spectrum of the real-world population of patients with AL amyloidosis in Italy; 3. Investigate the clinical utility of novel diagnostic technologies, including light chain sequencing and N-glycosylation analysis

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (4)

Azienda Ospedaliera Policlinico ConsorzialeBari, ItalyRecruiting
Azienda Ospedaliero Universitaria Policlinico G.Rodolico - San MarcoCatania, ItalyRecruiting
Fondazione Irccs Policlinico San MatteoPavia, ItalyRecruiting
EMATOLOGIA - Città della Scienza e Salute - TorinoTorino, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06383143